Shanghai Pharmaceuticals , China’s second-largest distributor of pharmaceutical products, will raise up to HK$16.6 billion ($2.13 billion) from its Hong Kong IPO, IFR reported on Thursday.
The company plans to price its offering in a range of HK$22.5-$25.0 per share, IFR, a Thomson Reuters publication said, citing bankers and investors close to the deal.
